Anti-eNOS (phospho S1177) antibody [EPR20991] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal eNOS phospho S1177 antibody. Carrier free. Suitable for IP, Dot, WB and reacts with Human, Mouse, Synthetic peptide samples. Cited in 5 publications.
View Alternative Names
Nitric oxide synthase 3, Constitutive NOS, EC-NOS, NOS type III, cNOS, NOSIII, Endothelial NOS, eNOS, NOS3
- IP
Supplier Data
Immunoprecipitation - Anti-eNOS (phospho S1177) antibody [EPR20991] - BSA and Azide free (AB230158)
eNOS (phospho S1177) was immunoprecipitated from 0.35 mg of HUVEC (human umbilical vein endothelial cell line) treated with 10 ng/ml VEGF for 5 min, whole cell lysate with ab215717 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab215717 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HUVEC treated with VEGF whole cell lysate 10 μg (Input).
Lane 2 : ab215717 IP in HUVEC treated with VEGF whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab215717 in HUVEC treated with VEGF whole cell lysate.
Exposure time : 30 seconds.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
The 60 kDa band may be a cleaved form of eNOS (PMID : 16195740).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab215717).
All lanes:
Immunoprecipitation - Anti-eNOS (phospho S1177) antibody [EPR20991] (<a href='/en-us/products/primary-antibodies/enos-phospho-s1177-antibody-epr20991-ab215717'>ab215717</a>)
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
- WB
Supplier Data
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] - BSA and Azide free (AB230158)
Blocking/Dilution buffer : 5% NFDM/TBST.
The 60 kDa band may be a cleaved form of eNOS (PMID : 16195740).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab215717).
All lanes:
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (<a href='/en-us/products/primary-antibodies/enos-phospho-s1177-antibody-epr20991-ab215717'>ab215717</a>) at 1/1000 dilution
Lane 1:
Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 10 µg
Lane 2:
HUVEC (human umbilical vein endothelial cell line) treated with 10 ng/ml VEGF for 5 min, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
Exposure time: 3min
- Dot
Supplier Data
Dot Blot - Anti-eNOS (phospho S1177) antibody [EPR20991] - BSA and Azide free (AB230158)
Dot blot analysis of eNOS (phospho S1177) labeled with ab215717 at 1/1000 dilution.
Lane 1 : eNOS (phospho S1177) peptide.
Lane 2 : eNOS non-phospho peptide.
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Exposure time : 1 minute.
Blocking/Dilution buffer : 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab215717).
Related conjugates and formulations (1)
-
Anti-eNOS (phospho S1177) antibody [EPR20991]
Reactivity data
Product details
ab230158 is the carrier-free version of ab215717.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ENOS contributes significantly to the regulation of vascular tone and blood flow by promoting vasodilation. It does not function alone; instead it forms complexes with other proteins to exert its full effect. eNOS activity influences the process of angiogenesis inflammation modulation and platelet aggregation. Through its ability to produce nitric oxide eNOS acts as a signaling molecule helping maintain vascular homeostasis.
Pathways
ENOS is a critical player in the NO signaling pathway and interacts intricately with the PI3K/Akt pathway. Nitric oxide produced by eNOS has a role in signaling cascades that lead to vascular dilation and reduced blood pressure. The PI3K/Akt pathway regulates eNOS activity via phosphorylation enhancing NO production. Other proteins like caveolin-1 and calmodulin modulate eNOS impacting these pathways' outcomes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Biomedicines 11: PubMed37892970
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical biochemistry and nutrition 72:171-182 PubMed36936876
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:21789 PubMed34750450
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:646240 PubMed34177571
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 23:5349-5359 PubMed31131539
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com